India's medical devices sector, being one of the sunrise sectors is a dynamic and rapidly growing industry which has grown significantly during the last decade. It is a priority sector for the Government including under the Make in India Program. India is the 4th largest Asian medical devices market and is estimated at Rs. 90,000 crore (US$ 11 billion) in 2022 and is expected to grow to US$ 50 billion by 2030 with a CAGR of 16.4 %. A comprehensive policy framework has been implemented by the Government to capitalize on the sector's primary development drivers—increasing health care spending, rising affordability, and technological advancements—in order to ensure coordinated growth.

We work with large medical device manufacturers to build national and state level engagement strategies including a focus on policy advocacy, addressing regulatory challenges and building access programs. Our team beings an in depth understanding of the sector and possesses the ability to work across the diverse stakeholder ecosystem, building collaborations with a focus on access and business expansion. We guide our clients through the nuances of working with the public sector building a strong narrative that resonates among the diverse stakeholder group.

India’s education sector is estimated at USD 180 billion for FY20, expecting to reach USD 225 billion by FY25. India’s education system is one of the largest ecosystems in the world. The K-12 education ecosystem has 1.5 million schools, with 9.4 million teachers, and ~250 million students, while the higher education system has 53,620 institutions, 1.4 million teachers, and 35 million students. The internet penetration from the current 622 million users in India to an estimated 900 million by 2025 has further spurred the use of technology in education delivery.

The government is looking closely at this sector with the recently announced National Education Policy (NEP) which is expected to spur investment and introduce new opportunities for engagement and partnership. Amongst this, the NEP 2020 lays down the legislative framework for foreign universities to open Indian campuses, including possibly tackling legacy issues like repatriation of profits. The higher education segment in India is estimated to touch USD 35 billion by 2025. The India ed – tech market has also seen a boost with the K-12 ed-tech market expecting 6.3 times the growth between 2019-2022, while the post K-12 ed-tech market is expecting a 3.7 times growth in the same period. The sector is estimated to grow to USD 300 billion by 2031, as against its current size of USD 700-800 million.

Our teams have experience supporting market leaders in identifying relevant opportunities while addressing assessment challenges in K-12, higher education, and the workforce. We can assist clients build their brands in India through identified policy engagements with various Central and State government agencies shaping their assessment framework for education and skill development. Looked carefully at the intersection of research, training and assessment – built coalitions and executed wining propositions.

Sustainability is fast gaining traction in India with corporates becoming more conscious to the environmental impact of their operations. Recent regulatory developments have also attempted to inculcate this holistic view around reporting requirements. Programs, including those with a focus on Clean India and rejuvenating urban spaces continue to provide opportunities for public private partnership. Furthermore, programs such as Swachh Bharat (Clean India) Mission and the Smart Cities Mission present opportunities for the waste management sector.

With the growing impact of climate change, there are various sectors that have the opportunity to managing this impact; the government has also reiterated its commitment to rebuild India as a circular economy.

Leveraging our industry experience and strong network, we have the ability to help clients navigate the India opportunity giving them a holistic perspective of this dynamic landscape. Identifying India partners, structuring business opportunities with a focus on the circular economy as well as paving the way for impact investment and environmental sustainability are some of the areas where we work.

The Food & Beverages industry accounts for 3% of India's GDP and is the single largest employer with a 7.3 million workforce. The food and grocery market alone constitutes almost 65 per cent of the total retail market in India. This sector has over 39,000 registered units with fixed capital of USD 32 billion and aggregate output of around USD 158 billion. Revenue in this segment is expected to show an annual growth rate of 10.36% and a projected market volume of USD 11 billion. By 2030, India is slated to become the 5th largest consumer in the world, riding on the back of abundant raw material and a huge domestic market.

In addition, markets such as alcoholic beverages, are seeing immense growth due to changing demographics and lifestyles, including a growing young population and increasing urbanization. Innovation in various segments has put India on the map further contributing to the potential for new entries as well as growth of exiting brands - premiumization of the sector is a critical consideration. The sector however, remains highly regulated; each state has its own regulatory landscape making it tough for payers to navigate the nuances.

We bring understanding of the regulatory landscape with a team that has worked across critical stakeholder groups including Departments of Excise. We can support clients reach the right stakeholders and address areas as diverse as business continuity, tracking, meeting regulatory requirements including standards, pricing, labelling, amongst others.

In recent years, the infrastructure sector in India has been propelled by the Government through policy initiatives that ensure time-bound creation of sustainable infrastructure in the country. Covering power, bridges, dams, roads, and urban infrastructure, the sector has been a cornerstone of partnerships. The government has also continued to show its commitment to newer avenues such as renewable energy; a revamped, reforms-based and result-linked new power distribution sector scheme and a commitment to enhance transport infrastructure with a focus on technology.

The Government also announced the ambitious National Infrastructure Pipeline, with an allocation of USD 1.4 trillion for the years 2019-25. With over 7400 projects across sectors such as energy, roads, urban development and railways that amount to nearly 71% of the projected infrastructure investments in India, the NIP is the biggest infrastructure push exercise in India. There has been a continued attempt to explore newer avenues to fund India’s infrastructure needs including the setting up of the National Bank for Financing Infrastructure and Development and the launch of Infrastructure Investment Trusts as a new instrument of raising capital.

Our team brings experience working with large investors, providing strategic advisory on the impact of political, regulatory and business developments on future investment opportunities. We also bring experience in mapping the Indian investment landscape across roads (national & state), renewable energy, technology, mobility, power (generation, transmission & distribution) and working closely with Urban Local Bodies (ULBs) to deliver public private partnership opportunities .

The Indian pharmaceutical industry ranks third globally in pharmaceutical production by volume and is known for its generic medicines and low-cost vaccines. Considered as the ‘Pharmacy of the World’, the domestic pharmaceuticals sector is valued at USD 41 billion, with a potential to reach USD 65 billion by 2024 and USD 130 billion by 2030.

The sector has been accorded high priority and under the Atma Nirbhar (self-reliant) agenda and a bulk drugs park scheme has been introduced to boost the domestic production of APIs, KSMs, and bulk drugs. Up to 100%, FDI has been allowed through automatic route for Greenfield pharmaceuticals projects. For Brownfield pharmaceuticals projects, FDI allowed is up to 74% through automatic route and beyond that through government approval.

We bring in depth expertise in improving access to critical drugs in the areas of communicable and non-communicable diseases through collaborative partnerships with various levels of government. We can also support clients with their business critical regulatory challenges, identify and execute market expansion opportunities for existing and future pipeline products, working at the intersection of policy, business, and marketing support.